Skip to main content
Hit enter to search or ESC to close
Close Search
search
Menu
About us
Team
Companies
Stories
ESG
News
Contact
Investors
Keensight Connect
search
Press Release
Symeres acquires Exemplify BioPharma, further strengthening its strategic foothold in the US
By
WeAreBlow
October 25, 2022
No Comments
Download
Previous Post
Keensight Capital has reinforced its stake in Unither
Next Post
Keensight Capital wins Best Corporate Sustainability Strategy at the Private Equity Wire ESG AAA European Awards 2022
Close Menu
About us
Team
Companies
Stories
ESG
News
Contact
Investors
Keensight Connect
© 2023 – Keensight Capital. All rights reserved.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
OK
Terms & conditions
